Colinz Laboratories Limited
BSE: COLINZ.BO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Bombay Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Narayanan Kutty Menon
- Employees
- 69
- Headquarters
- Mumbai, India
- IPO year
- 2024
- Market cap
- ₹126.0M
- Website
- http://www.colinz.com
Loading COLINZ…
Loading profile data…Frequently asked questions about COLINZ
What does Colinz Laboratories Limited (COLINZ.BO) do?
Colinz Laboratories Ltd. engages in the manufacture of pharmaceutical formulations in the dosage forms of tablets, capsules, granules, liquid orals, injectable, ointments, and creams. The firm has certain products for gynecology, cardiology, and gastroenterology. Its products category includes allopathy, ayurvedics, and nutraceuticals. The compa...
Where does COLINZ.BO trade?
Colinz Laboratories Limited (COLINZ.BO) trades on the Bombay Stock Exchange.
What sector is COLINZ.BO in?
Colinz Laboratories Limited (COLINZ.BO) operates in the Healthcare sector, specifically in the Medical - Pharmaceuticals industry.
Who is the CEO of Colinz Laboratories Limited?
Narayanan Kutty Menon is the chief executive officer of Colinz Laboratories Limited (COLINZ.BO).
Where is Colinz Laboratories Limited headquartered?
Colinz Laboratories Limited is headquartered in India.
Does COLINZ.BO pay a dividend?
Colinz Laboratories Limited (COLINZ.BO) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did COLINZ.BO go public?
Colinz Laboratories Limited (COLINZ.BO) completed its initial public offering in 2024.